TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.

Lucas Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.